Legacy Private Trust Co. Has $4.94 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Legacy Private Trust Co. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,422 shares of the healthcare conglomerate’s stock after selling 846 shares during the quarter. Legacy Private Trust Co.’s holdings in UnitedHealth Group were worth $4,935,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the 4th quarter worth $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Finally, Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Trading Down 0.0%

Shares of UnitedHealth Group stock opened at $298.11 on Friday. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a market cap of $270.42 billion, a price-to-earnings ratio of 19.23, a PEG ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s 50-day moving average price is $435.12 and its 200-day moving average price is $496.39.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the company posted $6.91 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now directly owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.